COVID-19 updates: No unemployment benefits for vaccine refusal in this state
The state just announced new COVID emergency plans.
The United States has been facing a COVID-19 surge as the more contagious delta variant continues to spread.
More than 686,000 Americans have died from COVID-19 while over 4.7 million people have died from the disease worldwide, according to real-time data compiled by the Center for Systems Science and Engineering at Johns Hopkins University. The average number of daily deaths in the U.S. has risen about 20% in the last week, according to data from the Centers for Disease Control and Prevention and the U.S. Department of Health and Human Services.
The U.S. is continuing to sink on the list of global vaccination rates, currently ranking No. 46, according to data compiled by The Financial Times. Just 64.7% of Americans ages 12 and up are fully vaccinated against COVID-19, according to data from the CDC.
Latest headlines:
Washington state requests federal staff for overwhelmed hospitals
Washington state Gov. Jay Inslee sent a letter to the White House Monday requesting staffing resources to help the state's overwhelmed hospitals.
"Once the Delta variant hit Washington state, COVID-19 hospitalizations skyrocketed. From mid-July to late August, we saw hospitalizations double about every two weeks," Inslee wrote. "The hospitals have surged to increase staffed beds and stretch staff and have canceled most non-urgent procedures, but are still over capacity across the state."
"While there are hopeful signs that the current wave of infection is peaking, and some states are beginning to see declines, we have not yet seen that effect here," the governor said.
Washington state had already asked for 1,200 federal government staffers and is now "requesting the deployment of Department of Defense medical personnel to assist with the current hospital crisis," Inslee said.
2nd dose of J&J vaccine results in stronger protection, company says
A second dose of Johnson & Johnson's COVID-19 vaccine given two months after the first leads to stronger protection, the company said Tuesday.
Compared to the Pfizer and Moderna vaccines, Johnson & Johnson's single-shot vaccine always had slightly lower efficacy. Peak efficacy from the two-shot Pfizer and Moderna vaccines was 95% and 94%, respectively, against symptomatic illness, compared to 72% with J&J's one shot. But two Johnson & Johnson shots, given two months apart, resulted in a similarly high effectiveness level: 94% protection against any symptomatic infection in the U.S. and 100% against severe disease.
J&J chief scientific officer Dr. Paul Stoffels said the single-shot vaccine still provides "strong and long-lasting protection" while also being "easy to use, distribute and administer."
"At the same time," Stoffels said, "we now have generated evidence that a booster shot further increases protection against COVID-19 and is expected to extend the duration of protection significantly."
-ABC News' Sony Salzman
US records 1.1 million pediatric COVID-19 cases over past 5 weeks
The U.S. reported more than 225,000 child COVID-19 cases, marking the fourth consecutive week with over 200,000 new pediatric cases reported, according to a newly released weekly report from the American Academy of Pediatrics and the Children’s Hospital Association.
In the last five weeks alone, the country has reported more than 1.1 million pediatric cases, according to the organizations.
"The weekly figure is now about 26 times higher than it was in June, when just 8,400 pediatric cases were reported over the span of a week," the organizations wrote in their report.
The South accounted for about half --110,000-- of last week's pediatric cases, according to the report.
The organizations added that more than 2,200 children are hospitalized with a confirmed or suspected COVID-19 infection.
-ABC News' Arielle Mitropoulos
US deaths surpass 675,000, more than 1918 flu pandemic
The U.S. surpassed 675,000 coronavirus deaths Monday, according to Johns Hopkins University's Coronavirus Resource Center.
The 675,446 deaths since the pandemic began in March of 2020 now surpasses the deaths from the 1918 pandemic.
Although the seven-day average of new deaths is nowhere near the 3,600 deaths recorded in mid-January, the average has been increasing since mid-July, according to the U.S. Centers for Disease Control and Prevention.
The seven-day average of new deaths has gone from 191 on July 10 to 1,353 on Sept. 19, the CDC data showed.
The majority of recent deaths has been among unvaccinated Americans, according to the data.
UK and South Korea agree to swap COVID-19 vaccine doses
The United Kingdom and South Korea have agreed to share COVID-19 vaccine doses to mutually support the rollout of shots in each nation.
The U.K. will send 1 million of the Pfizer-BioNTech vaccine doses to South Korea to enhance their vaccination program, with the first batch of shots expected to arrive in the coming weeks. South Korea will return the same volume by the end of the year, as the U.K. presses ahead with its vaccine rollout and booster shot program over the winter months, according to a press release from the U.K. Department of Health and Social Care.
The swapping initiative, similar to the arrangement between the U.K. and Australia, will help South Korea toward hitting its target of administering a second dose to 70% of its population by the end of October.
"The Republic of Korea is a strategic partner for the UK and the sharing of one million vaccines benefits both countries as we help build resistance against COVID-19 and save lives," British Foreign Secretary Liz Truss said in a statement Tuesday.
The deal will have no impact on the U.K.'s ongoing vaccine rollout or booster shot program, nor will it effect the doses the country has already pledged to give to the global vaccine-sharing initiative COVAX. Almost 90% of people over the age of 16 in the U.K. are fully vaccinated against COVID-19, and Pfizer-BioNTech vaccine doses are not immediately required in the U.K. due to robust supply management, according to the U.K. Department of Health and Social Care.